Breast cancer is a genetically heterogeneous group of tumors and can be further subdivided into several types, including luminal estrogen receptor- and progesterone receptor-positive (ER+/PR+), human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative (ER−/PR−/HER2−) cancers. This evidence concerns the gene PGR and breast carcinoma.